Projects per year
Personal profile
Education
- 2006-2011 Ph.D., Microbiology & Immunology, Dalhousie University, Canada
- 2004-2006 M.S., Medical Biophysics, University of Toronto, Canada
- 2000-2004 B.S., Microbiology & Immunology, McGill University, Canada
Experience
Administrative Experience
- 2020- Chief of International Research, Office of Global Engagement, Taipei Medical University
- 2017-2020 Chief of Global Partnerships, Office of Global Engagement, Taipei Medical University
Academic Experience
- Committee Member/Co-Investigator/Mentor, Canadian Network on Hepatitis C (CanHepC), Canada
- Adjunct Professor, Department of Microbiology & Immunology, Dalhousie University, Canada
- 2019- Professor, Department of Microbiology and Immunology, School of Medicine, Taipei Medical University
- Adjunct Professor, International Ph.D. Program in Medicine, College of Medicine, Taipei Medical University
- Adjunct Professor, Ph.D. Program in Global Health and Health Security, College of Public Health, Taipei Medical University, Taiwan
- Adjunct Professor, Master Program in Global Health and Development, College of Public Health, Taipei Medical University
- 2016-2019 Associate Professor, Department of Microbiology and Immunology, School of Medicine, Taipei Medical University
- 2012-2016 Assistant Professor, Department of Microbiology and Immunology, School of Medicine, Taipei Medical University
- 2011-2012 Postdoc, IWK Health Center/Canadian Center for Vaccinology, Canada
Awards
- 2020 Taipei Medical University Outstanding Mentorship Award
- 2019 Taipei Medical University Outstanding Teaching Award
- 2018 Taipei Medical University Distinguished Faculty Award
- 2017 Taipei Medical University Young Investigator Award
- 2017 2nd 505(b)(2)-[Drug Repurposing-New Formulation]-Innovation Award
- 2016 Taipei Medical University Junior Research Investigators Award
- 2011 McCarlie Postdoctoral Award
- 2011 IWK Postdoctoral Award
Research Interests
- Molecular virology
- Viral vector engineering
- Viral oncolytics
- Hepatitis C virus
- Emerging viral infections
- Antivirals development
Related Link
Fingerprint
Dive into the research topics where Liang Tzung Lin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
以機轉與目標為導向開發天然抗病毒活性物質作為新興黃病毒感染之預防與治療藥物(3/3)
8/1/23 → 7/31/24
Project: A - Government Institution › b - National Science and Technology Council
-
Exploration of Immunogenic Transgene Capacity of Measles Virus-Based Oncolytic Vector
7/1/23 → 2/29/24
Project: A - Government Institution › b - National Science and Technology Council
-
使用納米過濾血漿衍生的免疫球蛋白去除伊波拉病毒之標準流程建立與驗證
3/1/23 → 2/29/24
Project: C - Project of Alliance › o - Chi Mei Medical Center
-
Mechanism-Driven and Target-Based Development of Natural Entry Inhibitors for Prophylactic/Therapeutic Treatment against Emerging Flaviviruses(2/3)
8/1/22 → 7/31/23
Project: A - Government Institution › b - National Science and Technology Council
-
以機轉與目標為導向開發天然抗病毒活性物質作為新興黃病毒感染之預防與治療藥物(2/3)
8/1/22 → 7/31/23
Project: A - Government Institution › b - National Science and Technology Council
-
Immunogenic cell death: The cornerstone of oncolytic viro-immunotherapy
Palanivelu, L., Liu, C. H. & Lin, L. T., Jan 23 2023, In: Frontiers in Immunology. 13, 1038226.Research output: Contribution to journal › Review article › peer-review
Open Access3 Citations (Scopus) -
Corrigendum to Berberine inhibits hepatitis C virus entry by targeting the viral E2 glycoprotein (Phytomedicine (2019) 53 (62–69), (S0944711318303064), (10.1016/j.phymed.2018.09.025))
Hung, T. C., Jassey, A., Liu, C. H., Lin, C. J., Lin, C. C., Wong, S. H., Wang, J. Y., Yen, M. H. & Lin, L. T., Jul 20 2022, In: Phytomedicine. 102, 154128.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Pandemic strategies with computational and structural biology against COVID-19: A retrospective
Liu, C. H., Lu, C. H. & Lin, L. T., Jan 2022, In: Computational and Structural Biotechnology Journal. 20, p. 187-192 6 p.Research output: Contribution to journal › Review article › peer-review
Open Access3 Citations (Scopus) -
Therapeutic Strategies against Ebola Virus Infection
Liu, C. H., Hu, Y. T., Wong, S. H. & Lin, L. T., Mar 1 2022, In: Viruses. 14, 3, 579.Research output: Contribution to journal › Review article › peer-review
Open Access4 Citations (Scopus) -
Validation of Viral Inactivation Protocols for Therapeutic Blood Products against Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)
Belem, W. F., Liu, C. H., Hu, Y. T., Burnouf, T. & Lin, L. T., Nov 2022, In: Viruses. 14, 11, 2419.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus)
Datasets
-
Small molecules targeting coxsackievirus A16 capsid inactivate viral particles and prevent viral binding
Lin, L. T. (Contributor), Li, Y. (Creator), Lin, C. (Contributor), Wang, J. Y. (Creator), Lin, C. (Contributor), Richardson, C. D. (Creator) & Liu, C. (Contributor), Taylor & Francis, 2019
DOI: 10.6084/m9.figshare.7936901.v2, https://doi.org/10.6084%2Fm9.figshare.7936901.v2
Dataset